PRGO:NYSE
Perrigo Company PLC
11,92 US$
arrow_upward
+0,68%(+0,080) 1 d
11,92 US$
0,00% (0,00)
bedtimeEfter stängning
Stängd: 1 maj, 16:00:06 GMT−4 · USD
search
Alla symboler
1 d
5 d
1 m
6 m
Hittills i år
1 år
5 år
MAX
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för PRGO …
Öppen
11,96 US$
Högt
12,01 US$
Lågt
11,73 US$
Börsvärde
1,64 md
Volym
1,73 mn
Utdelning
9,73 %
Kvartalsvis utdelning
0,29 US$
Ex-utdelningsdatum
29 maj 2026
52v högst
28,44 US$
52v lägst
9,23 US$
EPS
−10,12 US$
Beta
0,46
Utestående aktier
137,65 mn
Antal anställda
8 tn
Nyheter och artiklar
Från källor på webben
MarketBeat
·
för 3 dagar sedan
Perrigo Company plc Announces Quarterly Dividend of $0.29 (NYSE:PRGO)
Newser
·
för 4 veckor sedan
PRGO Stock Analysis: Perrigo Company plc Ordinary Shares 1.36% dip $10.85 outlook
Profil
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
Om Perrigo Company PLC
AI-innehåll kan innehålla fel. Läs mer